Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ResMed Inc. (RMD) vs Rush Street Interactive Inc (RSI) Price & Performance

ResMed Inc.Trade
Rush Street Interactive IncTrade

Price performance (Past 24H)

Key statistics

ResMed Inc. vs Rush Street Interactive Inc — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.89B), while Rush Street Interactive Inc trades at $26.65 (market cap $3.12B). The key difference: ResMed Inc. is far larger — about 10.2× Rush Street Interactive Inc's market cap, and ResMed Inc. pays a 1.19% dividend while Rush Street Interactive Inc pays none. Which is the better fit depends on your goals.

RMDRSI
Market Cap
$31.89B$3.12B
Sector
HealthTechnology
52-Week High
$283.28$34.52
52-Week Low
$182.82$15.89
Enterprise Value
$31.24B$2.79B
Dividend Yield
1.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ResMed Inc.

ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support at $218. The company reported strong Q4 2026 results with EPS of $2.95 beating estimates, and revenue grew 9% to a record $1.5 billion. However, weaker fiscal 2027 revenue guidance has pressured the stock. Fundamentals remain solid with a 26.94% net income margin and robust cash flow from operations of $1.75 billion in 2025.

The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.70 consensus price target, but near-term sentiment is cautious due to the soft sales forecast and ongoing legal investigations. Key risks include competitive pressures and execution on guidance. Institutional buying by firms like HSBC and Canada Pension Plan provides confidence in long-term value.

Rush Street Interactive Inc

Rush Street Interactive (RSI) trades at $27.02, up 1.27% today, with a bullish technical signal from moving averages and strong institutional interest. Recent Q2 2026 results showed record revenue of $393.8 million and net income of $29.3 million, beating EPS expectations. The company raised full-year 2026 guidance, reflecting robust growth in online casino and sports betting markets. Analyst consensus is strongly bullish with a $34.75 price target, indicating 29% upside potential from current levels.

The outlook for RSI is positive, driven by accelerating revenue growth and expanding market share, but risks include intense competition and regulatory scrutiny in the gambling sector. High valuation multiples like a P/E of 87.16 suggest elevated expectations, requiring continued execution. Institutional buying, such as BlackRock's $448 million investment in Q2 2026, supports confidence, though investors should monitor margin pressures from rising marketing costs.

Returns comparison

Trailing returns across standard periods

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD

About Rush Street Interactive Inc

Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.

Read more on RSI